Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹943.90down ₹15.90 (1.66%)BSE ₹945.35
Share price at the NSE close on 28 Oct 2026. Previous close ₹959.80.
28 Oct: open ₹953.30, high ₹959.80, low ₹936.40
52-week range of traded prices to 27 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,288 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 37.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.52%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 57,068
Jubilant Pharmova dividends
23 filed, newest first.
May 2025
May 2024
29 May · Dividend
May 2023
May 2022
Jun 2021
Feb 2020
May 2019
May 2018
May 2017
Aug 2016
May 2016
Aug 2015
May 2015
12 May · Dividend
Board of Directors at its meeting held on May 12, 2015, has recommended a dividend of Rs. 3 per equity share of Rs. 1 fully paid up amounting to Rs. 5751 lacs (including dividend distribution tax), subject to approval in the Annual General Meeting.
May 2014
28 May · Dividend
Dividend, if approved, by the Members at the Annual General Meeting, will be paid/despatched on or before October 01, 2014.26 May · Dividend
Board of Directors of the Company at its meeting held on May 26, 2014 has recommended a dividend of Rs. 3 per equity shares of Rs. 1 fully paid up amounting to Rs. 5590 lacs, subject to approval in the Annual General Meeting.
May 2013
8 May · Dividend
Board of Directors of the Company at its meeting held on May 07, 2013 has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1/- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid / dispatched on or before September 26, 2013.
May 2012
7 May · Dividend
Board of Directors of the Company at its meeting held on May 07, 2012, has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1 /- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid/despatched on or before September 27, 2012.
May 2011
10 May · Dividend
Board of Directors of the Comapny at its meeting held on May 10, 2011 has recommended a dividend of Rs. 2 (Rupees Two) per share of Re. 1/- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid on or before September 22, 2011.
May 2010
10 May · Dividend
Board of Directors at its meeting held on May 10, 2010 has recommended a dividend of Rs. 2.00 per equity shares of Rs.1 amounting to Rs.3703 Lacs, subject to approval in the annual general meeting.
Apr 2009
28 Apr · Dividend
Board of Directors at their meeting held on April 28, 2009 has recommended a dividend of Rs. 1.50 per equity share of Re. 1 totaling to Rs. 2589.25 lacs, subject to approval in Annual General Meeting.
Apr 2008
22 Apr · Dividend
Board of Directors of the Company at its Meeting held on April 22, 2008 has recommended a dividend of Rs. 1.50 per equity share of Re. 1 totaling to Rs. 256.55 million, subject to approval in Annual General Meeting.
Apr 2007
27 Apr · Dividend
Board, at its meeting held on April 27, 2007, has recommended a dividend of Rs.1.25 per equity share of Re.1/- each.